Verve Therapeutics
VERV
#7012
Rank
A$0.63 B
Marketcap
$7.46
Share price
5.43%
Change (1 day)
-59.48%
Change (1 year)

Verve Therapeutics (VERV) - Total debt

Total debt on the balance sheet as of September 2024 : A$0.10 Billion

According to Verve Therapeutics's latest financial reports the company's total debt is A$0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Verve Therapeutics - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.10 B-8.67%
2022-12-31A$0.12 B4364.04%
2021-12-31A$2.69 M
2020-12-31N/A